Developing new reporting guidelines for the early-stage clinical evaluation of decision support systems driven by artificial intelligence.
Much like IDEAL 2a/2b studies, robust early formative evaluation, with an emphasis on the human users, is a necessary bridge from the development of clinical decision support systems driven by artificial intelligence (AI) to their implementation and paves the way toward large-scale summative evaluation. The objective of DECIDE-AI is to improve reporting along four main axes:
A Delphi process with an international group of over 120 experts is currently being conducted and the guidelines are expected for the second half of 2021.
Image: we have a logo very close to completion, which should be available in the coming 2-3 weeks.
Link to Correspondence in Nature Medicine: https://www.nature.com/articles/s41591-021-01229-5
Link to the systematic review performed as part of the preliminary investigations: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777403
Contact: Baptiste Vasey, firstname.lastname@example.org